T. Rowe Price Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $103K | Sell |
|
|||||
|
2022
Q2 | $222K | Sell |
|
|||||
|
2022
Q1 | $349K | Buy |
|
|||||
|
2021
Q4 | $433K | Buy |
|
|||||
|
2021
Q3 | $446K | Buy |
|
|||||
|
2021
Q2 | $449K | Sell |
|
|||||
|
2021
Q1 | $575K | Buy |
|
|||||
|
2020
Q4 | $352K | Buy |
|
|||||
|
2020
Q3 | $343K | Sell |
|
|||||
|
2020
Q2 | $441K | Sell |
|
|||||
|
2020
Q1 | $492K | Sell |
|
|||||
|
2019
Q4 | $891K | Buy |
|
|||||
|
2019
Q3 | $201K | Buy |
|
|||||
|
2019
Q2 | $442K | Buy |
|
|||||
|
2019
Q1 | $733K | Buy |
|
|||||
|
2018
Q4 | $473K | Sell |
|
|||||
|
2018
Q3 | $5.32M | Sell |
|
|||||
|
2018
Q2 | $14.4M | Sell |
|
|||||
|
2018
Q1 | $18M | Sell |
|
|||||
|
2017
Q4 | $60.1M | Sell |
|
|||||
|
2017
Q3 | $111M | Sell |
|
|||||
|
2017
Q2 | $190M | Buy |
|
|||||
|
2017
Q1 | $17.4M | Sell |
|
|||||
|
2016
Q4 | $19.5M | Sell |
|
|||||
|
2016
Q3 | $46.2M | Sell |
|
|||||
|
2016
Q2 | $20.9M | Sell |
|
|||||
|
2016
Q1 | $30M | Sell |
|
|||||
|
2015
Q4 | $55.4M | Sell |
|
|||||
|
2015
Q3 | $178M | Sell |
|
|||||
|
2015
Q2 | $196M | Sell |
|
|||||
|
2015
Q1 | $169M | Buy |
|
|||||
|
2014
Q4 | $124M | Buy |
|
|||||
|
2014
Q3 | $57.5M | Sell |
|
|||||
|
2014
Q2 | $54M | Buy |
|
|||||
|
2014
Q1 | $74.6M | Buy |
|
|||||
|
2013
Q4 | $55M | Buy |
|
|||||
|
2013
Q3 | $44.8M | Sell |
|
|||||
|
2013
Q2 | $59.3M | Buy |
|